240 related articles for article (PubMed ID: 38416185)
1. Increased cardiovascular risk in patients with chronic kidney disease.
Vondenhoff S; Schunk SJ; Noels H
Herz; 2024 Mar; 49(2):95-104. PubMed ID: 38416185
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
[TBL] [Abstract][Full Text] [Related]
4. Heart and kidney disease: a cardiovascular high-risk constellation.
Schunk SJ; Speer T; Fliser D
Herz; 2021 Jun; 46(3):206-211. PubMed ID: 33377985
[TBL] [Abstract][Full Text] [Related]
5. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
6. [Chronic kidney disease-a cardiovascular high-risk constellation].
Speer T; Schunk SJ; Fliser D
Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
[TBL] [Abstract][Full Text] [Related]
7. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
[TBL] [Abstract][Full Text] [Related]
8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A
Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia and cardiovascular disease in patients with and without kidney disease: what do we know?
Gungor O; Sevinc M; Ulu S; Kocyigit I
Int Urol Nephrol; 2023 May; 55(5):1161-1171. PubMed ID: 36327007
[TBL] [Abstract][Full Text] [Related]
12. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease.
Figuer A; Alique M; Valera G; Serroukh N; Ceprían N; de Sequera P; Morales E; Carracedo J; Ramírez R; Bodega G
Nefrologia (Engl Ed); 2023; 43(1):63-80. PubMed ID: 37268501
[TBL] [Abstract][Full Text] [Related]
13. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu.
Spahia N; Rroji M; Barbullushi M; Spasovski G
Metab Syndr Relat Disord; 2023 Oct; 21(8):415-425. PubMed ID: 37433213
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
Tomey MI; Winston JA
Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease measures for cardiovascular risk prediction.
Mok Y; Ballew SH; Matsushita K
Atherosclerosis; 2021 Oct; 335():110-118. PubMed ID: 34556333
[TBL] [Abstract][Full Text] [Related]
18. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
19. Animal Protein Intake and Possible Cardiovascular Risk in People With Chronic Kidney Disease: Mechanisms and Evidence.
Kelly JT; Gonzalez-Ortiz A; St-Jules DE; Carrero JJ
Adv Kidney Dis Health; 2023 Nov; 30(6):480-486. PubMed ID: 38453263
[TBL] [Abstract][Full Text] [Related]
20. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan.
Kadowaki T; Maegawa H; Watada H; Yabe D; Node K; Murohara T; Wada J
Diabetes Obes Metab; 2022 Dec; 24(12):2283-2296. PubMed ID: 35929483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
